Dynamically borrowing strength from another study

by   Christian Röver, et al.

Meta-analytic methods may be used to combine evidence from different sources of information. Quite commonly, the normal-normal hierarchical model (NNHM) including a random-effect to account for between-study heterogeneity is utilized for such analyses. The same modeling framework may also be used to not only derive a combined estimate, but also to borrow strength for a particular study from another by deriving a shrinkage estimate. For instance, a small-scale randomized controlled trial could be supported by a non-randomized study, e.g. a clinical registry. This would be particularly attractive in the context of rare diseases. We demonstrate that a meta-analysis still makes sense in this extreme two-study setup, as illustrated using a recent trial and a clinical registry in Creutzfeld-Jakob disease. Derivation of a shrinkage estimate within a Bayesian random-effects meta-analysis may substantially improve a given estimate even based on only a single additional estimate while accounting for potential effect heterogeneity between the studies. The proposed approach is quite generally applicable to combine different types of evidence originating e.g. from meta-analyses or individual studies. An application of this more general setup is provided in immunosuppression following liver transplantation in children.


page 1

page 2

page 3

page 4


Bayesian random-effects meta-analysis using the bayesmeta R package

The random-effects or normal-normal hierarchical model is commonly utili...

Bounds for the weight of external data in shrinkage estimation

Dynamical borrowing of information may be facilitated via shrinkage esti...

Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis

In Bayesian meta-analysis, the specification of prior probabilities for ...

Model averaging for robust extrapolation in evidence synthesis

Extrapolation from a source to a target, e.g., from adults to children, ...

Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint

The recent 21st Century Cures Act propagates innovations to accelerate t...

Applying Meta-Analytic Predictive Priors with the R Bayesian evidence synthesis tools

Use of historical data in clinical trial design and analysis has shown v...

Methods for the inclusion of real world evidence in network meta-analysis

Background: Network Meta-Analysis (NMA) is a key component of submission...